EGenesis

About:

EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.

Website: https://www.egenesisbio.com

Twitter/X: egenesisbio

Top Investors: Khosla Ventures, Alexandria Venture Investments, ARCH Venture Partners, Invus, Fresenius Medical Care

Description:

EGenesis is a biotechnology company developing solid organ and therapeutic cell transplantation to treat diseases. It offers gene editing and genome engineering platform to develop human-compatible organs, tissues, and cells, aiming to provide an alternative solution to the global organ shortage.

Total Funding Amount:

$456M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2014-01-01

Contact Email:

info(AT)egenesisbio.com

Founders:

Geoff MacKay, George Church, Luhan Yang

Number of Employees:

101-250

Last Funding Date:

2024-09-04

IPO Status:

Private

© 2025 bioDAO.ai